Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy
Clinical trial NCT05694598 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05694598
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2024-09-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.